Pancreatectomy for NET: External Evaluation of WHO 2017 Grading System (PanTEN)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03791346|
Recruitment Status : Completed
First Posted : January 1, 2019
Last Update Posted : April 18, 2019
Aim: The aim of this study was to investigate the clinicopathological factors and to evaluate the prognostic accuracy of the new World Health Organization (WHO) 2017 grading system in pancreatic neuroendocrine tumor (PanNET) patients.
Methods: Data collected between 1997 and December 2017 were analyzed. Histological grading and staging was based on the WHO 2017 grading system. Outcome after surgery and predictors of overall survival (OS) and disease free survival (DFS) were evaluated.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||138 participants|
|Official Title:||Outcome After Pancreatectomy for Neuroendocrine Tumor and Evaluation of the WHO 2017 Grading System: a Retrospective Multicentric Analysis of 138 Consecutive Patients.|
|Actual Study Start Date :||January 1, 1997|
|Actual Primary Completion Date :||December 1, 2017|
|Actual Study Completion Date :||February 1, 2019|
- Disease-free survival at 5 years [ Time Frame: 5 years ]Disease-free survival (percentage of patients without recurrence) at 5 years. Disease-free survival (DFS) (time from diagnosis to time of first radiological evidence of local, regional, or distant relapse, or death due to any cause)
- Overall survival at 5 years [ Time Frame: 5 years ]Overall survival (OS) (time from diagnosis until death, regardless of cause)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03791346
|Montpellier, France, 34295|
|Study Director:||REGIS SOUCHE||University Hospital, Montpellier|